Jiangsu Favored Nanotechnology (688371.SH) released a profit forecast, with an estimated net profit of 38 to 50 million yuan for the year 2024, turning losses into profits.

22/01/2025

GMT Eight

Jiangsu Favored Nanotechnology (688371.SH) announced that the company expects to achieve a net profit attributable to the owners of the parent company of 38-50 million yuan in 2024, turning losses into profits compared to the same period last year.

Harbin Pharmaceutical Group (600664.SH): Cefuroxime Sodium for Injection passes generic drug consistency evaluation.

Financial Street Holdings (000402.SZ): Shanghai Rongyue Center CMBS officially established.

Contact: contact@gmteight.com

Jiangsu Favored Nanotechnology (688371.SH) released a profit forecast, with an estimated net profit of 38 to 50 million yuan for the year 2024, turning losses into profits.

RECOMMEND

LingNan Eco & Culture-Tourism (002717.SZ) forecasts a pre-loss of between 900 million and 1.35 billion for the year 2024.

Anhui Sinonet & Xinlong Science & Technology (002298.SZ) issued a forecasted loss, predicting a net loss of 1.2 billion to 1.56 billion yuan for the fiscal year 2024, with an expanding loss.

"The king of Wall Street" issues a new warning: Stock valuations in the US may be "slightly overvalued"